MedTrace Logo

The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens

NCT01626300 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2017-06-21

No results posted yet for this study

Summary

The purpose of this study is to determine if the daily use of a certain amount and type of milk component for 2 months provides a significant stimulation to the immune system and specifically increases the chances of being protected against pneumonia after the vaccination.

Conditions

  • The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-12-31
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01626300 on ClinicalTrials.gov